Start for free
Start for free
Blackstone Life Sciences logo

Blackstone Life Sciences

North America, Massachusetts, United States, Cambridge

Description

Blackstone Life Sciences is a private equity segment of The Blackstone Group.

Investor Profile

Blackstone Life Sciences has made 16 investments, with 2 in the past 12 months and 56% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series C (19%)
  • Series B (13%)
  • Series A (13%)
  • Post Ipo Debt (6%)

Country Focus

  • United States (94%)
  • France (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Precision Medicine
  • Health Diagnostics
  • Alternative Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Blackstone Life Sciences frequently co-invest with?

Irving Investors
Irving Investors
North America, Colorado, United States, Denver
Co-Investments: 2
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 4
Farallon Capital Management
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Eventide
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 3
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
BlackRock
BlackRock
North America, New York, United States, New York
Co-Investments: 3
AP
Co-Investments: 1
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Blackstone Life Sciences?

AvenCell

Watertown, Massachusetts, United States

Based on our deep science and focused on patients in need.

Health Care
Series BOct 22, 2024
Amount Raised: $112,000,000
Uniquity Bio

Malvern, Pennsylvania, United States

Uniquity Bio operates as a drug development company.

BiotechnologyMedical
Series AMay 15, 2024
Amount Raised: $300,000,000
Moderna

Cambridge, Massachusetts, United States

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityMar 27, 2024
Amount Raised: $750,000,000
Amicus Therapeutics

Cranbury, New Jersey, United States

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityOct 2, 2023
Amount Raised: $30,000,000
Sutro Biopharma

South San Francisco, California, United States

Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.

BiotechnologyInformation TechnologyMedical
Post Ipo DebtJun 26, 2023
Amount Raised: $140,000,000
PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityOct 27, 2022
Amount Raised: $1,000,000,000
Sanofi

Paris, Ile-de-France, France

Sanofi is a healthcare company that provides treatments and the protection of life-saving vaccines.

Health CareLife SciencePharmaceuticalTherapeutics
Post Ipo EquityMar 15, 2022
Amount Raised: $329,024,935
Harmony Biosciences

Plymouth Meeting, Pennsylvania, United States

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityAug 10, 2021
Amount Raised: $30,000,000
Imago BioSciences

San Carlos, California, United States

Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.

BiotechnologyLife ScienceTherapeutics
Series CNov 19, 2020
Amount Raised: $80,000,000
Talaris Therapeutics

Louisville, Kentucky, United States

Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies.

BiotechnologyHealth CareTherapeutics
Series BOct 6, 2020
Amount Raised: $115,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator